The activities of the Let’s Talk Prostate Cancer (LTPC) Expert Group are funded by Astellas Pharma Inc., Agen Inc and Pfizer Inc, which collectively contribute to and support the objectives of the Expert group.
Astellas Pharma Inc. have full and exclusive editorial control over the LTPC Website

About the Digital Atlas

The LTPC Digital Atlas brings together data from a wide range of sources, providing a visual and interactive platform to compare prostate cancer incidence, mortality, survival, medicines expenditure and cancer care spending across the EU. The country profiles provide an overview of the specific outcomes for that country, details of the prostate cancer care pathway as set out within the national clinical guidelines for prostate cancer, as well as a list of the main prostate cancer patient organisations.

The Atlas shows the variance between EU countries in terms of the political and clinical approach to supporting prostate cancer patients. We believe this variance must be reduced, and that all European countries and policymakers should work together to ensure that every patient in Europe receives the right treatment at the right time and a care and support programme tailored to their needs.

Europe Digital Atlas